This is a serious illness caused by a virus found in certain animals, like rodents and bats. It spreads to people through the bite of an infected insect, like a mosquito or tick. It can cause bleeding problems and is often very dangerous.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
American hemorrhagic fever is a group name for several rare but serious viral infections found in parts of South America. Each is caused by a related virus from the arenavirus family that lives in wild rodents. The best known are Argentine hemorrhagic fever (Junin virus) and Bolivian hemorrhagic fever (Machupo virus). Venezuelan (Guanarito virus) and Brazilian (Sabia virus) hemorrhagic fevers, and illness from the Chapare virus in Bolivia, are rarer still. The illness usually begins like a bad flu, with fever, tiredness, headache and aching muscles. In some people it then progresses to bleeding, nervous system problems and a dangerous drop in blood pressure. "Hemorrhagic" refers to that tendency to bleed. Because early treatment can change the outcome, recognizing the illness in its first week matters a great deal. These viruses are different from other hemorrhagic fevers such as dengue, Ebola, Lassa fever or hantavirus, even though early symptoms can look alike.
People catch these viruses mainly by breathing in dust or tiny droplets contaminated with the urine, droppings or saliva of infected wild rodents. The rodents carry the virus for long periods without becoming ill and shed it into soil, crops and stored grain. Disturbing that material, for example while harvesting, handling grain or cleaning storage areas, can stir the virus into the air. Risk is therefore tied to place and activity. Argentine hemorrhagic fever occurs in the farming plains (the Pampas) of central Argentina, and Bolivian hemorrhagic fever in rural northeastern Bolivia. Most cases are in rural farm workers, especially men of working age, and cases tend to rise with harvest seasons and when rodent numbers are high. Spread from one person to another is rare, but it can happen through direct contact with an ill person's blood or body fluids, and infections in healthcare and laboratory workers have been documented. Cases outside the affected regions are very rare and have occurred in travelers.
Diagnosis starts with a clinician connecting the symptoms to where the person has been. The first days of illness look like many other fevers, including flu, dengue and leptospirosis (a bacterial infection also spread by animal urine), so a recent stay in an affected rural area is the key clue. Routine blood and urine tests often show a low white blood cell count, a low platelet count (platelets are the cells that help blood clot) and protein in the urine. These findings support the suspicion but cannot confirm it. Confirmation comes from specialized tests: a polymerase chain reaction (PCR) test that detects the virus's genetic material in blood, most useful in the first week or so, and antibody tests, which usually become positive from the end of the first week. Because these viruses are dangerous to handle, samples are sent to designated reference laboratories, and staff use infection control precautions while the diagnosis is being worked out.
Treatment depends on which virus is involved, and timing is central. For Argentine hemorrhagic fever, the established specific treatment is immune plasma: plasma donated by people who have recovered, which contains antibodies that neutralize the virus. It works only when given within the first week of illness (about 8 days from the first symptoms). In a controlled trial, deaths fell from about 1 in 6 people given ordinary plasma to about 1 in 100 given immune plasma early. Its limits are that it must come from screened donors, supplies can be hard to maintain, and it does not help once the illness has advanced. For Bolivian hemorrhagic fever and the other forms, there is no licensed vaccine or specific antiviral treatment. Ribavirin, an antiviral drug, has been tried when immune plasma is not available, but it has not been shown to reduce deaths and is still under study. For every form, hospital supportive care is the foundation: careful management of fluids and blood salts, monitoring of blood counts and nervous system function, platelet or other blood transfusions for serious bleeding, and treatment of any bacterial infections that develop. People who are very ill may need intensive care.
The illness tends to move in stages. The first week brings fever, weakness, aches, a flushed face and sometimes bleeding gums or small red spots on the skin. Many people recover from this stage, especially with early treatment. Without it, roughly 20 to 30 percent of people with Argentine hemorrhagic fever enter a severe stage around days 8 to 12, with significant bleeding, confusion, tremor or seizures, and shock. Historically, 15 to 30 percent of untreated Argentine cases were fatal, and Bolivian outbreaks have had similar or higher death rates. Early immune plasma has made death uncommon in Argentine cases treated in time. Recovery is slow. Fatigue, irritability, memory difficulties and hair loss can last one to three months. About 1 in 10 people treated with immune plasma develop a late neurological syndrome after a period of feeling well, with fever, unsteadiness and problems with nerves that control the face or eyes. Follow-up after discharge allows this to be recognized. In Argentina, a vaccine called Candid #1 is given to people at risk in affected areas and has greatly reduced the number of cases. It protects only against the Argentine form. Reducing contact with rodents, keeping them out of homes and grain stores, and avoiding stirring up rodent-contaminated dust also lower risk.
If you develop a fever within three weeks (21 days) of being in a rural area of Argentina or Bolivia, or of caring for someone with suspected infection, seek medical care the same day and tell the clinician about the trip or exposure. For the Argentine form, treatment that works best must start within the first week of symptoms, so waiting to see if the fever passes can cost the chance to give it. Bleeding from the gums, nose or in vomit, stool or urine, new confusion, severe shakiness, a seizure or fainting in someone with suspected or diagnosed infection needs emergency care right away. After recovery, contact your care team promptly if fever, unsteadiness or new problems with eye or face movements appear in the weeks after leaving the hospital.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with American Hemorrhagic Fever is like, what's helped you, or ask the community a question.